University of Tampere

University of Tampere

The University of Tampere embraces many fields of science and its research profile is extensive and multidisciplinary. There are six faculties and nine independent institutes. The University of Tampere is the biggest provider of higher education in Finland for social sciences and the accompanying administrative sciences. Every year approximately one thousand master's degrees and one hundred doctoral degrees are produced. Some 15,200 students are currently pursuing degrees at the University of Tampere. Every year approximately one thousand master's degrees and one hundred doctoral degrees are produced. The personnel number about 2,100. The Chancellor of the University is Ms Krista Varantola, the Rector is Ms Kaija Holli and the Administrative Director is Mr Timo Lahti.

Tampere, the home city of the University is the third biggest city in Finland. There are also
activities in smaller towns of Hämeenlinna, Pori, Seinäjoki, Valkeakoski and Virrat. Approximately one million people live in the area over which the influence of the University extends.

The Institute of Medical Technology (IMT) is an independent research and educational institute of the
University of Tampere, founded in 1995. IMT is dedicated to modern biomedical research, and to the
provision of high quality education at undergraduate (see MSc Programme), graduate (see IMT
Graduate Programme) and postdoctoral levels in natural sciences related to biotechnology and
molecular biology. The Master of Science programme has started in 2001 and is jointly run by IMT,
Tampere Technical University and the Medical School of Tampere University. The programme
provides a novel type of training with a special emphasis on modern biomedical research and
biotechnology. The IMT Graduate Programme provides state-of-the-art research training at doctoral
level to both science graduates and medical students oriented towards basic science.
IMT is one of the five Finnish Biocenters receiving earmarked biotechnology funding from the Ministry
of Education. The annual budget for IMT in 2003 was nearly 7 M€ of which 45% came from the
Ministry of Education and 55% was competitive funding to research groups from the Academy of
Finland, EU, NIH, Medical Research Fund of Tampere University Hospital and private Foundations.
IMT currently houses sixteen research groups with a personnel of over 150, located in modern
research facilities in Finn-Medi I and Finn-Medi II buildings, which are directly connected to the
Tampere University Hospital. IMT also has close relations with the Medical School of Tampere
University and with Tampere Technical University. IMT is led by a ten member Board that represents
the University of Tampere, plus the faculty and staff of IMT, as well as surrounding institutions, such
as the City of Tampere, the University Hospital, Medical School, and biotechnology companies. The
Board nominates the Director of IMT for a five year term.
Research programmes in IMT cover two broad areas, namely molecular genetics of human disease,
and molecular mechanisms of immune responses and disorders. The current genetics programmes
focus on cytoskeletal abnormalities and genetic aberrations involved in the pathogenesis of cancer, in
particular kidney, prostate and breast tumors, and on the role of mitochondrial mutations in human
disorders such as diabetes, deafness and cardiomyopathy. The newly created, Academy of Finlandsupported
"Centre of Excellence" FinMIT (Finnish Research Unit on Mitochondrial Biogenesis and
Disease), is a core component of the institute. FinMIT is co-ordinated from IMT, but also includes
researchers based in the University of Helsinki. The topics of the Immunology programmes include the
molecular basis of the autoimmune disorders APECED and coeliac disease, as well as the HIV-1
pathogenicity factor Nef, and cytokine- and antigen-induced transcriptional regulation. The
bioinformatics group at IMT provides expertise in data mining and molecular modelling to the entire
research community, but also has


Visiting address
Kalevantie 4
33100 Tampere, Finland
Mailing address
FI-33014 University of Tampere



Contact person

Round Robin Experiment

Raman spectroscopy has already proved its effectiveness in many cases for medical diagnostics such as for cancer, cardiovascular diseases and infections. However, there are no standards in the different working groups, e.g. for sample preparation, implementation of the Raman experiments, spectra pre-treatment, data evaluation, etc.In a round robin experiment, the required groundwork will take place in order to define standardised Raman measurement methods, which will be fundamental for establishing Raman spectroscopy for clinical diagnostic procedures.

Latest News

5th International Conference on Biophotonics

20 March 2017

Continuing the success of the previous meetings held in Sacramento, Ottawa, Jena, and Florence, the 5th conference will come to Perth, Western Australia, running over two full days, and back-to-back with the Science on the Swan medical research conference, which delegates are strongly encouraged to also attend, at discounted rates. [more]

Biophotonics Wiki

Visit our wiki to consult our latest technologies and techniques. [more]


Subscribe to our newsletter and get information about Photonics- 4Life:

Photonics4Life RSS Feed